IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAROSI, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.417
EU - Europa 7.032
AS - Asia 5.153
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
SA - Sud America 10
Totale 29.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.360
CN - Cina 2.875
UA - Ucraina 2.802
DE - Germania 1.177
IT - Italia 1.097
SG - Singapore 945
HK - Hong Kong 651
FI - Finlandia 589
IE - Irlanda 435
TR - Turchia 410
GB - Regno Unito 373
IN - India 215
FR - Francia 179
SE - Svezia 139
PL - Polonia 99
CA - Canada 51
BE - Belgio 50
RU - Federazione Russa 32
MU - Mauritius 22
EU - Europa 20
IR - Iran 20
AU - Australia 17
NL - Olanda 13
CZ - Repubblica Ceca 11
LT - Lituania 6
JP - Giappone 5
AE - Emirati Arabi Uniti 4
BR - Brasile 4
CH - Svizzera 4
HU - Ungheria 4
KR - Corea 4
MX - Messico 4
NG - Nigeria 4
VN - Vietnam 4
ES - Italia 3
HR - Croazia 3
ID - Indonesia 3
RO - Romania 3
ZA - Sudafrica 3
AR - Argentina 2
BD - Bangladesh 2
IL - Israele 2
MY - Malesia 2
PT - Portogallo 2
SA - Arabia Saudita 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
IQ - Iraq 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LR - Liberia 1
MA - Marocco 1
MD - Moldavia 1
MS - Montserrat 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SO - Somalia 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 29.686
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.188
Fairfield 2.160
Jacksonville 2.079
Houston 1.185
Wilmington 1.143
Ashburn 1.106
Ann Arbor 1.023
Cambridge 949
Chandler 944
Nanjing 836
Princeton 807
Seattle 799
Singapore 741
Hong Kong 650
Dublin 434
Istanbul 348
Nanchang 287
New York 258
Beijing 252
Des Moines 197
Shenyang 197
Helsinki 184
Hebei 175
Changsha 159
San Diego 147
Tianjin 137
Jiaxing 130
Jinan 127
Dearborn 119
Milan 110
Warsaw 99
Kunming 93
Verona 77
Hangzhou 76
Shanghai 75
Lancaster 59
Kocaeli 56
Brussels 50
Brescia 49
Zhengzhou 49
Lanzhou 46
Ningbo 41
Los Angeles 40
Boardman 37
Toronto 37
Taizhou 32
Leawood 28
Guangzhou 27
San Francisco 27
Washington 26
Norwalk 25
London 24
Haikou 23
Munich 20
Rome 20
Pune 19
Augusta 18
Ardabil 16
Changchun 16
Taiyuan 15
Fuzhou 13
Romola 12
Auburn Hills 11
Falls Church 11
Frankfurt am Main 11
Brno 10
Monmouth Junction 10
Orange 10
San Mateo 9
Catania 8
Rende 8
Hefei 7
Melbourne 7
Ottawa 7
Redmond 7
Santa Clara 7
Chicago 6
Hanover 6
Kilburn 6
Torino 6
Napoli 5
Palermo 5
Redwood City 5
Venezia 5
Bologna 4
Dong Ket 4
Dubai 4
Folignano 4
Islington 4
Messina 4
Nürnberg 4
Padova 4
Pavia 4
Phoenix 4
Shaoxing 4
Southwark 4
Sydney 4
Bergamo 3
Berlin 3
Brandizzo 3
Totale 21.344
Salva come PNG Salva come JPEG
Nome #
Cos’è la Medicina Tropicale 224
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA 208
Hepatitis C infection influence on immune recovery in HIV-positive patients on successful HAART: The role of genotype 3 158
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 157
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 155
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 145
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 140
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 139
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 138
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 134
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 134
HIV-associated asymmetric lipodystrophy syndrome 126
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis 124
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 123
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 123
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 123
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 123
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone 122
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment 122
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 122
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 122
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 121
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 120
Accidental and transfusion malaria in Italy 118
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and Human Immunodeficiency Virus. 117
Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution. 115
STI epidemics in the Indian Ocean Region: can the phase be assessed? 114
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 113
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 113
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. 112
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 112
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month 112
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 112
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 111
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. 111
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 109
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 108
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 107
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target? 106
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 105
Interleukin-2 therapy in patients with HIV infection 105
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 105
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 104
Epidemiological features and case-management practices of imported malaria in northern Italy 104
Mortality for liver disease in patients with HIV infection: a cohort study 104
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 103
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 103
Filariasis in travelers presenting to the Geosentinel Surveillance Network 103
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 103
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 103
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 102
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. 102
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 102
Polymorphic immune restoration syndrome after effective HAART 102
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 102
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 101
High prevalence of radiological vertebral fractures in HIV-infected males 101
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 101
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 100
Fatal disseminated toxoplasmosis during primary HIV infection. 100
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis 100
HIV-related liver disease: ARV drugs, coinfection, and other risk factors. 100
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of Foscarnet versus Ganciclovir. 100
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 100
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 100
Malaria and HIV in adults: When the parasite runs into the virus 100
Baggage Malaria in Italy: Cryptic Malaria explained? 99
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. 99
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 99
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina 99
Adherence to surgical site infection guidelines in Italian cardiac surgery units. 99
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load 99
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006 98
Risk factors for myocardial infarction in HIV positive patients 98
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006). 97
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects 97
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 97
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. 96
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy). 96
Towards HCV extinction with modern HCV treatment? “Yes we can!” 96
Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. 95
Outcome and predictive factors of mortality in hospitalized HIV-patients in Burkina Faso 95
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 95
Anti-viral potency of HAART regimens and clinical success are not strictly coupled in real life conditions. Evidence from the MASTER-1 Study 94
Clinical presentation and outcome of hepatocellular carcinoma in HIV infected patients. 94
Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin 94
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 94
Analysis of current guidelines for intra-abdominal infections 94
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial 94
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 93
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008 93
Class of antiretroviral drugs and the risk of myocardial infarction. 93
Adherence to hand hygiene in an Italian long-term care facility. 93
Italian consensus statement on paediatric HIV infection 93
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 93
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 93
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma 92
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 91
Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. 91
I data-base clinici e la sorveglianza degli eventi avversi: il progetto MASTER 90
Totale 10.981
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.783 0 0 0 0 341 833 629 818 431 1.086 139 506
2020/20214.995 53 604 283 742 137 609 118 590 876 339 529 115
2021/20222.828 125 538 11 185 31 170 94 190 168 433 282 601
2022/20232.769 457 24 31 232 268 820 3 272 424 25 86 127
2023/20242.154 138 68 128 149 82 370 57 53 663 23 17 406
2024/20251.515 26 18 28 594 849 0 0 0 0 0 0 0
Totale 30.094